Updates in Proper Use and Administration of Long-Acting Injectable Antipsychotics-Presentation Slides

Presentation Slides

Pdf Summary

The document provides information on proper use and administration of long-acting injectable antipsychotics (LAIs) for the treatment of serious mental illnesses. It discusses the different types of LAIs available, the indications for use, and the recommended dosing strategies and administration techniques for each medication. It also highlights the importance of preventing medication errors associated with prescribing, dispensing, preparation, and administration of LAIs. The document emphasizes the need for healthcare professionals to be knowledgeable about the specific characteristics of each LAI, such as the route of administration, needle size, and injection site, in order to ensure safe and effective use. Furthermore, it mentions the occurrence of post-injection delirium/sedation syndrome (PDSS) with olanzapine pamoate and the importance of adherence to the Risk Evaluation and Mitigation Strategy (REMS) program for this medication. Overall, the document aims to raise awareness about best practices in the use and administration of LAIs to improve patient outcomes and minimize medication errors.

Keywords

long-acting injectable antipsychotics

LAIs

treatment

serious mental illnesses

medication errors

healthcare professionals

specific characteristics

post-injection delirium/sedation syndrome

olanzapine pamoate

Risk Evaluation and Mitigation Strategy